Continuing Education & Accreditation Information
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Christian Medical & Dental Associations and Catholic Healthcare International.
The Christian Medical & Dental Associations is accredited by the ACCME to provide continuing medical education for physicians.
The Christian Medical & Dental Associations designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nursing
This activity has been submitted to Georgia Nurses Association for approval to award contact hours. Georgia Nurses Association is an accredited approver of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. Determination of credit is pending.
AAFP
Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.
Physician Assistant
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits<sup>™</sup> by an organization accredited by the ACCME or a recognized state medical society. Physician assistants may receive up to 5.5 credits for completing this activity.
Nurse Practitioner
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts AMA PRA Category 1 Credits<sup>™</sup> from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines. Nurse practitioners may receive up to 5.5 credits for completing this activity.
Educational Objectives
Upon completion of this activity, participants should be able to:
- Define the biological development stages of the human embryo from fertilization through early organogenesis (zygote → blastocyst → embryo).
- Identify the embryological evidence (genetic uniqueness, continuous development, onset of cardiac activity) that supports recognition of the embryo as a distinct human organism from conception.
- Analyze common scientific, legal, and philosophical objections to full moral status for embryos and critically evaluate their validity in light of current embryological data.
- Evaluate how recognition of the embryo’s humanity from conception should inform ethical clinical practice, especially in OB-GYN settings, assisted reproductive technologies (ART), and perinatal care.
- Recognize policies and care protocols for clinicians and institutions that protect embryonic life, respect human dignity, and align with Catholic bioethical principles.
- Define the biological and clinical status of cryopreserved human embryos as living human organisms.
- Identify the medical, ethical, and legal challenges associated with long-term embryo cryopreservation and disposition.
- Analyze moral arguments surrounding embryo storage, destruction, research use, and “embryo adoption.”
- Evaluate clinical responsibilities in counseling patients about embryo creation, storage, and disposition options.
- Recommend ethically sound institutional policies that protect embryonic human life and maintain professional integrity.
- Define from theological and philosophical perspectives what constitutes a human person and describe how this applies to the embryo from conception.
- Identify key Christian-theological and biblical concepts (e.g., creation in the image of God, human dignity, the commandment to love one’s neighbor) that underpin the moral status of the embryo.
- Analyze prominent secular and medical arguments that deny full moral status to embryos — such as gradualist or “developmentbased” approaches — and compare them with the theological-personhood view.
- Evaluate contemporary bioethical theories and medical literature regarding embryo status and moral standing, in light of theological moral principles.
- Recommend how clinicians, researchers, and institutions can adopt practices, policies, and professional commitments that uphold the dignity and protection of embryonic human life.
- Describe the biological and clinical realities of early human development and embryo viability.
- Identify ethical and professional risks associated with IVF, embryo cryopreservation, and embryo disposition practices.
- Analyze real-world clinical and research cases involving embryos, using sound bioethical reasoning.
- Evaluate how moral, theological, and professional standards can be integrated into clinical decision-making under institutional or legal pressure.
- Recommend ethically sound, life-affirming strategies for patient counseling, policy development, and professional advocacy.
- Define ethical courage and moral integrity in the context of modern clinical practice.
- Identify institutional and societal pressures that challenge adherence to the Hippocratic Oath and Church teaching.
- Analyze strategies to maintain professional and moral boundaries in ethically complex or controversial situations.
- Evaluate approaches for fostering a culture of conscience protection and life-affirming care within healthcare institutions.
- Recommend practical methods for staying faithful to ethical, moral, and Church-guided standards in daily practice.
- Define the core principles of a Christian ethic of end-of-life care, including the sanctity of life and the moral limits of palliative interventions.
- Identify practices that constitute ethically permissible pain and symptom management versus interventions that intentionally hasten death.
- Analyze clinical scenarios in light of Christian moral principles and professional ethical standards.
- Evaluate current institutional and legal trends related to end-of-life care and their implications for ethical practice.
- Recommend strategies for providing compassionate, life-affirming care while upholding moral and professional integrity.
- Describe the historical and legal origins of brain death criteria in the United States (e.g., UDDA, clinical guidelines).
- Identify the standard clinical and ancillary tests used to determine brain death, and explain their limitations or potential for misdiagnosis.
- Evaluate arguments for and against brain death as a valid definition of human death from both medical and ethical perspectives.
- Analyze the ethical implications of accepting or rejecting brain death criteria for medical practice, patient rights, and organ donation policies.
- Define the clinical practices of palliative sedation and terminal analgesia, and distinguish them from active life-ending interventions.
- Identify major ethical and clinical critiques of applying the Doctrine of Double Effect to end-of-life sedation and analgesia, based on recent peer-reviewed scholarship.
- Analyze the moral risks posed by deep sedation or continuous opioid regimens — especially the potential for intentional or de facto euthanasia under the guise of “pain relief.”
- Evaluate when sedation and analgesia may — or may not — meet morally acceptable criteria for end-of-life care from a Catholic bioethical perspective.
- Recommend ethically sound protocols for pain and symptom management at end of life that respect human dignity, preserve the possibility of spiritual preparation, and avoid life-ending intent.
CE WELCOME LETTER
Continuing Education Information:
All participants are required to review the CMDA CE Welcome Letter, which contains accreditation information, disclosures, and additional requirements for this activity.